The global biologics market is predicted to touch USD 425 million at an 10.50% CAGR between 2020- 2030, according to the new report by Market Research Future (MRFR). Biologics simply put, are drugs that are available in the form of genetically engineered proteins that are derived from the human gene. It is composed of nucleic acids, proteins, sugars, or its complex combinations, or living entities like tissues and cells. Biologic drugs are made from different natural sources like microorganisms, animals, or humans and comprise products like tissues, gene therapy, somatic cells, allergenics, blood blood components, vaccines, and recombinant therapeutic proteins.